| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
disease | 0.400 | None | 0.967 | 6 | 0 | 2002 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.400 | None | 1.000 | 6 | 0 | 1998 | 2019 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1987 | 2019 | ||||||||
|
heat shock protein family B (small) member 1 | 0.436 | 0.808 | 2.8E-07 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 2005 | 2018 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.985 | 3 | 0 | 1985 | 2020 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.400 | None | 0.879 | 3 | 0 | 1995 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.980 | 3 | 0 | 1995 | 2019 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
disease | 0.400 | None | 0.950 | 3 | 0 | 1988 | 2020 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1992 | 2020 | ||||||||
|
microRNA 122 | 0.468 | 0.808 |
|
disease | 0.400 | None | 0.993 | 3 | 0 | 2006 | 2020 | |||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.857 | 3 | 0 | 1995 | 2020 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.400 | None | 0.985 | 2 | 0 | 1985 | 2019 | ||||||||
|
gap junction protein beta 1 | 0.514 | 0.731 | 0.85 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1990 | 2019 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2018 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.400 | None | 0.963 | 2 | 0 | 1996 | 2019 | ||||||||
|
aurora kinase A | 0.475 | 0.731 | 0.87 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2004 | 2019 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1990 | 2020 | ||||||||
|
Jun proto-oncogene, AP-1 transcription factor subunit | 0.442 | 0.885 | 6.0E-02 |
|
disease | 0.400 | None | 0.950 | 2 | 0 | 1993 | 2020 | ||||||||
|
epoxide hydrolase 1 | 0.500 | 0.846 | 3.2E-09 |
|
disease | 0.400 | None | 0.769 | 2 | 0 | 1995 | 2020 | ||||||||
|
MAGE family member A1 | 0.601 | 0.462 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1999 | 2017 | |||||||||
|
COP9 signalosome subunit 5 | 0.566 | 0.769 | 1.00 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2003 | 2018 | ||||||||
|
marker of proliferation Ki-67 | 0.431 | 0.808 | 1.3E-28 |
|
disease | 0.400 | None | 0.917 | 2 | 0 | 1995 | 2018 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2007 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.983 | 2 | 0 | 2007 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.967 | 2 | 0 | 1993 | 2020 |